NCT02386657View on ClinicalTrials.gov

Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

June 30, 2016

Conditions
Sickle Cell Disease
Interventions
OTHER

Satisfaction

Satisfaction questionnaire to be filled in

OTHER

Biological parameters

Measure of standard routine biological parameters (Hb, GB, Plaq, LDH, CRP, TCA, INR, D Dimers) and dosage of nitrous albumin (PNA).

OTHER

Pain management

Validated pain scale questionnaire to be filled in

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT02386657 - Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department | Biotech Hunter | Biotech Hunter